Last update 01 Nov 2024

Tatsumi Kagaku Co., Ltd.

Holding Company|
1941|
Tokyo-to, Japan
|
www.tatsumi-kagaku.com

Overview

Tags

Other Diseases
Nervous System Diseases
Immune System Diseases
Small molecule drug

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Disease DomainCount
Endocrinology and Metabolic Disease1
Hemic and Lymphatic Diseases1
Immune System Diseases1
Nervous System Diseases1
Neoplasms1
Top 5 Drug TypeCount
Small molecule drug2
Top 5 TargetCount
GR(Glucocorticoid receptor)1
DDC x DRDs1

Related

2
Drugs associated with Tatsumi Kagaku Co., Ltd.
Carbidopa/Levodopa
Target
DDC x DRDs
Mechanism
DDC inhibitors [+1]
Active Org.
Daito Pharmaceutical Co., Ltd.Daito Pharmaceutical Co., Ltd. [+14]
Originator Org.
Merck & Co., Inc.Merck & Co., Inc.
Active Indication
Parkinsonian Disorders [+7]
Inactive Indication
Complication [+2]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date02 May 1975
Prednisolone
Target
GR
Mechanism
GR agonists
Active Org.
Shionogi Pharma Co., Ltd. [+2]
Originator Org.
Pfizer Inc.Pfizer Inc.
Active Indication
Mucocutaneous Lymph Node Syndrome [+3]
Inactive Indication
Adrenal Insufficiency [+15]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date21 Jun 1955
100 Clinical Results associated with Tatsumi Kagaku Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Tatsumi Kagaku Co., Ltd.
Login to view more data
100 Deals associated with Tatsumi Kagaku Co., Ltd.
Login to view more data
100 Translational Medicine associated with Tatsumi Kagaku Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 07 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Approved
2
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Carbidopa/Levodopa
 ( DDC x DRDs )		Parkinsonian Disorders
More
Approved
Prednisolone
 ( GR )		Eczema
More
Approved
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free